The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2008 by Shaheed Beheshti Medical University. Recruitment status was Recruiting

First Received on October 16, 2006. Last Updated on January 22, 2008 History of Changes

Sponsor:	Shaheed Beheshti Medical University
Information provided by:	Shaheed Beheshti Medical University
ClinicalTrials.gov Identifier:	NCT00388778

Purpose

The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.

Condition	Intervention	Phase
Acne Inflammation	Drug: Doxycycline	Phase II Phase III

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment
Official Title:	The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne

Resource links provided by NLM:

MedlinePlus related topics: Acne

Drug Information available for: Doxycycline Doxycycline hyclate Doxycycline calcium

U.S. FDA Resources

Further study details as provided by Shaheed Beheshti Medical University:

Estimated Enrollment:	100
Study Start Date:	October 2005
Estimated Study Completion Date:	October 2006

Eligibility

Ages Eligible for Study:	18 Years to 40 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Acne

Exclusion Criteria:

Pregnancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00388778

Contacts

Contact: Parviz Toossi, M.D.

98-21-22744392

src@sbmu.ac.ir

Locations

Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University	Recruiting
Tehran, Iran, Islamic Republic of, 19899
Contact: Parviz Toossi, M.D. 98-21-22744392 src@sbmu.ac.ir
Principal Investigator: Parviz Toossi, M.D.
Sub-Investigator: Nahid Mohtasham, MD

Sponsors and Collaborators

Shaheed Beheshti Medical University

Investigators

Principal Investigator:

Parviz Toossi, M.D.

Shaheed Beheshti Medical University

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00388778 History of Changes
Other Study ID Numbers:	src-pts-964
Study First Received:	October 16, 2006
Last Updated:	January 22, 2008
Health Authority:	Iran: Ethics Committee

Additional relevant MeSH terms:

Acne Vulgaris
Inflammation
Acneiform Eruptions
Skin Diseases
Facial Dermatoses
Sebaceous Gland Diseases
Pathologic Processes
Doxycycline

Doxycycline hyclate
Anti-Bacterial Agents
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Antimalarials
Antiprotozoal Agents
Antiparasitic Agents

ClinicalTrials.gov processed this record on February 09, 2012